Markus Fido, Ph.D.
Chief Executive Officer
Managing Director / Founder
Besides serving as a formal Managing Director, Markus has also taken responsibilities as a Head of Regulatory Affairs within the Quality Operations team. Additionally, he is in charge of business development items and client relations topics.
He was previously Head Quality Control at Igeneon/Aphton Biopharma where he was responsible for all QC aspects of pre-clinical and clinical projects such as stability studies, specifications, method validation, and product release. Before he was Group Leader of Immunology and Product Development at Biomin GmbH, Head Biochemical Control at Baxter AG and Head Quality Operations at Octapharma GmbH. He has more than 20 years of experience in pharmaceutical industry, with focus in vaccines, recombinant proteins and immune therapeutics. He has profound expertise in regulatory aspects such as third party audits, authority inspections and GMP guidelines. He has a management consulting education and holds a doctorate degree in chemistry/biochemistry from the Technical University of Graz, Austria.
Klaus Hajszan, DI (FH)
Head Quality Assurance / Qualified Person
Klaus Hajszan is the responsible Qualified Person (QP) for VelaLabs and in addition holds the position of Head Quality Assurance.
He was previously assistant to general practitioner Dr. Helmuth Greiner and then joined VelaLabs serving firstly as Senior Technician QC and Head Quality Control. He has more than 10 years of experience in the medical field and biotechnology industry. His experience includes protein analytics, quality control, quality assurance, and a profound knowledge of protein development (characterization, (pre)clinical studies). Furthermore, he works as lector on international conferences (GMP, analytics, and method transfer).
Markus Roucka DI (FH)
Markus Roucka is the Chief Operating Officer (COO) of VelaLabs and has also responsibilities in Business Development.
He started his career at Biomin GmbH as a R&D employee for fermentation optimization and QC in microbiology. During his study at the University of Applied Sciences for medical and pharmaceutical biotechnology (IMC Krems) he went to the UMCG Groningen and searched for new therapies for non-small cell lung cancer within his master thesis. At VelaLabs he started as Senior Technician and further as Head Laboratory for many years. He has more than 10 years of work experience in biotechnology industry including protein characterization under GMP regulations (biosimilars, biopharmaceuticals, biologics) with a focus on assay development and optimization. His main experience is dedicated to cell culture based methods, flow cytometry and SPR (Biacore) related methods.